Erste Asset Management’s PTC Therapeutics PTCT Stock Holding History

Erste Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-48,600	Closed	-$2M	–	575
2023 Q2	$2M	Hold	48,600	–	–	0.04%	289
2023 Q1	$2.37M	Hold	48,600	–	–	0.05%	276
2022 Q4	$1.8M	Hold	48,600	–	–	0.04%	288
2022 Q3	$2.45M	Hold	48,600	–	–	0.05%	264
2022 Q2	$1.96M	Hold	48,600	–	–	0.04%	283
2022 Q1	$1.81M	Buy	48,600 +6,800	+16%	+$262K	0.03%	309
2021 Q4	$1.7M	Hold	41,800	–	–	0.03%	309
2021 Q3	$1.55M	Hold	41,800	–	–	0.03%	293
2021 Q2	$1.76M	Hold	41,800	–	–	0.04%	295
2021 Q1	$1.96M	Hold	41,800	–	–	0.05%	271
2020 Q4	$2.65M	Sell	41,800 -16,000	-28%	-$943K	0.07%	238
2020 Q3	$2.73M	Hold	57,800	–	–	0.09%	212
2020 Q2	$2.93M	Buy	57,800 +15,000	+35%	+$737K	0.12%	184
2020 Q1	$1.82M	Sell	42,800 -35,500	-45%	-$1.79M	0.11%	194
2019 Q4	$3.82M	Hold	78,300	–	–	0.17%	136
2019 Q3	$2.71M	Hold	78,300	–	–	0.14%	155
2019 Q2	$3.38M	Buy	+78,300	New	+$3.09M	0.18%	133

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Erste Asset Management's PTCT Position: Q3 2023 in Review

Erste Asset Management sold out of PTC Therapeutics (PTCT) in Q3 2023, closing a stake of 48,600 shares — an estimated $2M sold.

Erste Asset Management first reported a position in PTCT in Q2 2019 and held it in 17 quarters. The position peaked at $3.82M in Q4 2019. 179 funds tracked by Wall St. Rank hold PTCT as of Q3 2023.

Erste Asset Management reported no remaining PTC Therapeutics position as of Q3 2023 after selling out during the quarter.
Erste Asset Management sold 48,600 PTC Therapeutics shares in Q3 2023, an estimated $2M.
Erste Asset Management first reported a position in PTC Therapeutics in Q2 2019 and held it in 17 quarters.
Erste Asset Management's PTC Therapeutics position peaked at $3.82M in Q4 2019.
179 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2023.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.